BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34885960)

  • 1. Modulating Properties of Piroxicam, Meloxicam and Oxicam Analogues against Macrophage-Associated Chemokines in Colorectal Cancer.
    Lewandowska P; Szczuka I; Bednarz-Misa I; Szczęśniak-Sięga BM; Neubauer K; Mierzchała-Pasierb M; Zawadzki M; Witkiewicz W; Krzystek-Korpacka M
    Molecules; 2021 Dec; 26(23):. PubMed ID: 34885960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat Shock Proteins HSPA1 and HSP90AA1 Are Upregulated in Colorectal Polyps and Can Be Targeted in Cancer Cells by Anti-Inflammatory Oxicams with Arylpiperazine Pharmacophore and Benzoyl Moiety Substitutions at Thiazine Ring.
    Szczuka I; Wierzbicki J; Serek P; Szczęśniak-Sięga BM; Krzystek-Korpacka M
    Biomolecules; 2021 Oct; 11(11):. PubMed ID: 34827586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of cytokine-induced changes in leukocyte adhesion receptors by nonsteroidal antiinflammatory drugs from the oxicam family.
    García-Vicuña R; Díaz-González F; González-Alvaro I; del Pozo MA; Mollinedo F; Cabañas C; González-Amaro R; Sánchez-Madrid F
    Arthritis Rheum; 1997 Jan; 40(1):143-53. PubMed ID: 9008610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-Arginine/Nitric Oxide Pathway Is Altered in Colorectal Cancer and Can Be Modulated by Novel Derivatives from Oxicam Class of Non-Steroidal Anti-Inflammatory Drugs.
    Krzystek-Korpacka M; Szczęśniak-Sięga B; Szczuka I; Fortuna P; Zawadzki M; Kubiak A; Mierzchała-Pasierb M; Fleszar MG; Lewandowski Ł; Serek P; Jamrozik N; Neubauer K; Wiśniewski J; Kempiński R; Witkiewicz W; Bednarz-Misa I
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32932854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between chemokines CCL2, CCL3, and CCL4 with the tumor microenvironment and tumor-associated macrophage markers in colorectal cancer.
    De la Fuente López M; Landskron G; Parada D; Dubois-Camacho K; Simian D; Martinez M; Romero D; Roa JC; Chahuán I; Gutiérrez R; Lopez-K F; Alvarez K; Kronberg U; López S; Sanguinetti A; Moreno N; Abedrapo M; González MJ; Quera R; Hermoso-R MA
    Tumour Biol; 2018 Nov; 40(11):1010428318810059. PubMed ID: 30419802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Possibilities of individual choice of NSAIDs on the example of the oxicam class, taking into account clinical and pharmacological characteristics].
    Putilina MV; Teplova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(7):36-41. PubMed ID: 35904290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxicams bind in a novel mode to the cyclooxygenase active site via a two-water-mediated H-bonding Network.
    Xu S; Hermanson DJ; Banerjee S; Ghebreselasie K; Clayton GM; Garavito RM; Marnett LJ
    J Biol Chem; 2014 Mar; 289(10):6799-6808. PubMed ID: 24425867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocyte Chemotactic Proteins (MCP) in Colorectal Adenomas Are Differently Expressed at the Transcriptional and Protein Levels: Implications for Colorectal Cancer Prevention.
    Wierzbicki J; Lipiński A; Bednarz-Misa I; Lewandowski Ł; Neubauer K; Lewandowska P; Krzystek-Korpacka M
    J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte chemotactic protein-1 regulates leukocyte recruitment during gastric ulcer recurrence induced by tumor necrosis factor-alpha.
    Watanabe T; Higuchi K; Hamaguchi M; Shiba M; Tominaga K; Fujiwara Y; Matsumoto T; Arakawa T
    Am J Physiol Gastrointest Liver Physiol; 2004 Oct; 287(4):G919-28. PubMed ID: 15205118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Inflammatory Oxicams as Multi-donor Ligand Systems: pH- and Solvent-Dependent Coordination Modes of Meloxicam and Piroxicam to Ru and Os.
    Aman F; Hanif M; Kubanik M; Ashraf A; Söhnel T; Jamieson SM; Siddiqui WA; Hartinger CG
    Chemistry; 2017 Apr; 23(20):4893-4902. PubMed ID: 28198061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual coordinating behavior by three non-steroidal anti-inflammatory drugs from the oxicam family towards copper(II). Synthesis, X-ray structure for copper(II)-isoxicam, -meloxicam and -cinnoxicam-derivative complexes, and cytotoxic activity for a copper(II)-piroxicam complex.
    Cini R; Tamasi G; Defazio S; Hursthouse MB
    J Inorg Biochem; 2007 Aug; 101(8):1140-52. PubMed ID: 17592742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photophysical studies of oxicam group of NSAIDs: piroxicam, meloxicam and tenoxicam.
    Banerjee R; Chakraborty H; Sarkar M
    Spectrochim Acta A Mol Biomol Spectrosc; 2003 Apr; 59(6):1213-22. PubMed ID: 12659890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of MIP-2 (CXCL2) expression by 15-deoxy-Delta(12,14)-prostaglandin J(2) in mouse peritoneal macrophages.
    Kim HY; Kim HS
    Immunol Cell Biol; 2007 Jan; 85(1):60-7. PubMed ID: 17130903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma.
    Tanaka S; Tatsuguchi A; Futagami S; Gudis K; Wada K; Seo T; Mitsui K; Yonezawa M; Nagata K; Fujimori S; Tsukui T; Kishida T; Sakamoto C
    Gut; 2006 Jan; 55(1):54-61. PubMed ID: 16085694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oxicam inhibitors of cyclooxygenase on oxidative stress generation in rat gastric mucosa. A comparative study.
    Villegas I; Martín MJ; La Casa C; Motilva V; De La Lastra CA
    Free Radic Res; 2002 Jul; 36(7):769-77. PubMed ID: 12180128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxicam structure in non-steroidal anti-inflammatory drugs is essential to exhibit Akt-mediated neuroprotection against 1-methyl-4-phenyl pyridinium-induced cytotoxicity.
    Tasaki Y; Yamamoto J; Omura T; Noda T; Kamiyama N; Yoshida K; Satomi M; Sakaguchi T; Asari M; Ohkubo T; Shimizu K; Matsubara K
    Eur J Pharmacol; 2012 Feb; 676(1-3):57-63. PubMed ID: 22182582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxicams, a class of nonsteroidal anti-inflammatory drugs and beyond.
    Xu S; Rouzer CA; Marnett LJ
    IUBMB Life; 2014 Dec; 66(12):803-11. PubMed ID: 25537198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic probing of model lipid membranes: phospholipase A2 activity toward monolayers modified by oxicam NSAIDs.
    Czapla K; Korchowiec B; Orlof M; Magnieto JR; Rogalska E
    J Phys Chem B; 2011 Jul; 115(29):9290-8. PubMed ID: 21682312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxicam-derived non-steroidal anti-inflammatory drugs suppress 1-methyl-4-phenyl pyridinium-induced cell death via repression of endoplasmic reticulum stress response and mitochondrial dysfunction in SH-SY5Y cells.
    Omura T; Sasaoka M; Hashimoto G; Imai S; Yamamoto J; Sato Y; Nakagawa S; Yonezawa A; Nakagawa T; Yano I; Tasaki Y; Matsubara K
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2963-2969. PubMed ID: 30107908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectroscopic studies of the binding of Cu(II) complexes of oxicam NSAIDs to alternating G-C and homopolymeric G-C sequences.
    Chakraborty S; Bose M; Sarkar M
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Mar; 122():690-7. PubMed ID: 24345609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.